Growth Metrics

Armata Pharmaceuticals (ARMP) Assets Average (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Assets Average for 5 consecutive years, with $11.2 million as the latest value for Q3 2018.

  • Quarterly Assets Average fell 22.67% to $11.2 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Sep 2018, down 22.67% year-over-year, with the annual reading at $14.6 million for FY2017, 41.0% down from the prior year.
  • Assets Average hit $11.2 million in Q3 2018 for Armata Pharmaceuticals, down from $13.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $39.4 million in Q1 2014 to a low of $11.2 million in Q3 2018.
  • Historically, Assets Average has averaged $25.3 million across 5 years, with a median of $28.8 million in 2016.
  • Biggest five-year swings in Assets Average: rose 8.3% in 2015 and later crashed 48.89% in 2017.
  • Year by year, Assets Average stood at $30.3 million in 2014, then rose by 8.3% to $32.8 million in 2015, then tumbled by 32.61% to $22.1 million in 2016, then crashed by 43.61% to $12.5 million in 2017, then dropped by 10.35% to $11.2 million in 2018.
  • Business Quant data shows Assets Average for ARMP at $11.2 million in Q3 2018, $13.1 million in Q2 2018, and $12.8 million in Q1 2018.